Based on bioinformatics analysis of public datasets as well as our in-house RNAscope data, TUBB2B is upregulated in brain metastasis (Fig. 1B and C), and its high expression predicts poorer DMFS in breast cancer patients (Fig. 1G). Here, TUBB2B is linked to breast cancer.